Literature DB >> 9576430

Decompensation of pressure-overload hypertrophy in G alpha q-overexpressing mice.

Y Sakata1, B D Hoit, S B Liggett, R A Walsh, G W Dorn.   

Abstract

BACKGROUND: Receptor-mediated activation of myocardial Gq signaling is postulated as a biochemical mechanism transducing pressure-overload hypertrophy. The specific effects of Gq activation on the functional and morphological adaptations to pressure overload are not known. METHODS AND
RESULTS: To determine the effects of intrinsic myocyte G alpha q signaling on the left ventricular hypertrophic response to experimental pressure overload, transgenic mice overexpressing G alpha q specifically in the heart (G alpha q-25) and nontransgenic siblings underwent microsurgical creation of transverse aortic coarctation and the morphometric, functional, and molecular characteristics of these pressure-overloaded hearts were compared at increasing times after surgery. Before aortic banding, isolated G alpha q-25 ventricular myocytes exhibited contractile depression (depressed +dl/dt and -dl/dt) and G alpha q-25 hearts showed a pattern of fetal gene expression similar to the known characteristics of nontransgenic pressure-overloaded mice. Three weeks after transverse aortic banding, G alpha q-25 left ventricles hypertrophied to a similar extent (approximately 30% increase) as nontransgenic mice. However, whereas nontransgenic mice exhibited concentric left ventricular remodeling with maintained ejection performance (compensated hypertrophy), G alpha q-25 left ventricles developed eccentric hypertrophy and ejection performance deteriorated, ultimately resulting in left heart failure (decompensated hypertrophy). The signature hypertrophy-associated progress of fetal cardiac gene expression observed at baseline in G alpha q-25 developed after aortic banding of nontransgenic mice but did not significantly change in aortic-banded G alpha q-25 mice.
CONCLUSIONS: Intrinsic cardiac myocyte G alpha q activation stimulates fetal gene expression and depresses cardiac myocyte contractility. Superimposition of the hemodynamic stress of pressure overload on G alpha q overexpression stimulates a maladaptive form of eccentric hypertrophy that leads to rapid functional decompensation. Therefore G alpha q-stimulated cardiac hypertrophy is functionally deleterious and compromises the ability of the heart to adapt to increased mechanical load. This finding supports a reevaluation of accepted concepts regarding the mechanisms for compensation and decompensation in pressure-overload hypertrophy.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9576430     DOI: 10.1161/01.cir.97.15.1488

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  59 in total

Review 1.  Cardiac hypertrophy and heart failure development through Gq and CaM kinase II signaling.

Authors:  Shikha Mishra; Haiyun Ling; Michael Grimm; Tong Zhang; Don M Bers; Joan Heller Brown
Journal:  J Cardiovasc Pharmacol       Date:  2010-12       Impact factor: 3.105

Review 2.  Mechanisms of non-apoptotic programmed cell death in diabetes and heart failure.

Authors:  Gerald W Dorn
Journal:  Cell Cycle       Date:  2010-09-07       Impact factor: 4.534

Review 3.  Death begets failure in the heart.

Authors:  Roger S-Y Foo; Kartik Mani; Richard N Kitsis
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

Review 4.  Protein kinase cascades in the regulation of cardiac hypertrophy.

Authors:  Gerald W Dorn; Thomas Force
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

5.  Cardiac 7-transmembrane-spanning domain receptor portfolios: diversify, diversify, diversify.

Authors:  Stephen B Liggett
Journal:  J Clin Invest       Date:  2006-04       Impact factor: 14.808

6.  Fatty acid synthase modulates homeostatic responses to myocardial stress.

Authors:  Babak Razani; Haixia Zhang; P Christian Schulze; Joel D Schilling; John Verbsky; Irfan J Lodhi; Veli K Topkara; Chu Feng; Trey Coleman; Attila Kovacs; Daniel P Kelly; Jeffrey E Saffitz; Gerald W Dorn; Colin G Nichols; Clay F Semenkovich
Journal:  J Biol Chem       Date:  2011-07-08       Impact factor: 5.157

7.  Activation of protein synthesis in cardiomyocytes by the hypertrophic agent phenylephrine requires the activation of ERK and involves phosphorylation of tuberous sclerosis complex 2 (TSC2).

Authors:  Mark Rolfe; Laura E McLeod; Phillip F Pratt; Christopher G Proud
Journal:  Biochem J       Date:  2005-06-15       Impact factor: 3.857

8.  Cardiac-specific overexpression of catalase identifies hydrogen peroxide-dependent and -independent phases of myocardial remodeling and prevents the progression to overt heart failure in G(alpha)q-overexpressing transgenic mice.

Authors:  Fuzhong Qin; Shannon Lennon-Edwards; Steve Lancel; Andreia Biolo; Deborah A Siwik; David R Pimentel; Gerald W Dorn; Y James Kang; Wilson S Colucci
Journal:  Circ Heart Fail       Date:  2009-12-16       Impact factor: 8.790

Review 9.  The rationale for cardiomyocyte resuscitation in myocardial salvage.

Authors:  Gerald W Dorn; Abhinav Diwan
Journal:  J Mol Med (Berl)       Date:  2008-06-19       Impact factor: 4.599

10.  Enhanced Galphaq signaling: a common pathway mediates cardiac hypertrophy and apoptotic heart failure.

Authors:  J W Adams; Y Sakata; M G Davis; V P Sah; Y Wang; S B Liggett; K R Chien; J H Brown; G W Dorn
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.